Details for New Drug Application (NDA): 070566
✉ Email this page to a colleague
NDA 070566 describes NITROPRESS, which is a drug marketed by Abbott, Abbvie, Hospira, and Vpna, and is included in four NDAs. Additional details are available on the NITROPRESS profile page.
The generic ingredient in NITROPRESS is sodium nitroprusside. There are one thousand four hundred and seventy-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
The generic ingredient in NITROPRESS is sodium nitroprusside. There are one thousand four hundred and seventy-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
Summary for 070566
| Tradename: | NITROPRESS |
| Applicant: | Hospira |
| Ingredient: | sodium nitroprusside |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/VIAL | ||||
| Approval Date: | Jun 9, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
